
Video Channels

FEATURED VIDEOS
What is Ocular Melanoma?
Uveal Melanoma with Liver Metastases: Patient Experience, Treatment Challenges & Hope on the Horizon


Uveal Melanoma with Liver Metastases: Patient Experience, Treatment Challenges & Hope on the Horizon

Uveal Melanoma 2022 | C. Shields

Uveal Melanoma, A Modern Approach to Ocular Oncology | Tara McCannel, MD | UCLAMDChat

Choroidal Melanoma

Ocular Melanoma - See Your Eye Professional Today


FEATURED CHANNELS


Can cancer treatment impact my eyes and vision?
Many cancer treatments can affect your eyes and vision in a variety of ways. Some mild eye-related side effects, such as dryness or blurred vision, can resolve on their own, but serious side effects can impact your vision in the long term.

American Society of Retina Specialists
Multiple, Successive Branch Retinal Artery Occlusions in a Patient with Antiphospholipid Syndrome


Multiple, Successive Branch Retinal Artery Occlusions in a Patient with Antiphospholipid Syndrome

Clinical Characteristics and Outcome of Delayed Diagnosis of Intraocular Foreign Bodies

IOI, Safety Events and Outcomes After Intravitreal Anti-VEGF Injections for nAMD

The mission of The Eye Cancer Foundation is three-fold: to develop and encourage international, multi-center research on new diagnostic treatments; to provide much-needed support services for patients and their families; and to save lives through our international fellowship program by training doctors in underserved and unserved countries.
It has been our goal to create a world-class resource for patients and their families diagnosed with eye cancer in the form of ocular tumors, macular degeneration, and related ophthalmic conditions. We want to help you, your children and families around the world.
The Eye Cancer Foundation
2023 ISOO Fellow Presentations: Day 3


2023 ISOO Fellow Presentations: Day 3

2023 ISOO Fellow Presentations: Day 2

2023 ISOO Fellow Presentations: Day 1

Finding Your Way With Ocular Melanoma
Why Your Voice Matters: How Patients (Not Doctors) Move the Needle in MedicalProgress


Why Your Voice Matters: How Patients (Not Doctors) Move the Needle in MedicalProgress

Dr. Tara and Dr. Hsinyi Discuss Preventive Benefits of Blending East & Western Medicine

Dr.Tara and Dr.Hsinyi demonstrate Self-Acupressure for Pain Relief

The Melanoma Research Alliance
Advancing Discoveries,
Changing Lives, Curing Melanoma.
MRA is the world’s largest private nonprofit funder of melanoma research.
We’ve directly invested over $175 million toward scientific discoveries,
and we won’t stop until we achieve our mission of curing melanoma.
MelanomaReAlli
MRA Meet Up: Oncolytic Immunotherapy, Clinical Trials, & the Emerging RP1 Treatment


MRA Meet Up: Oncolytic Immunotherapy, Clinical Trials, & the Emerging RP1 Treatment

What Does Melanoma Research Mean to You?

Melanoma: Know the Facts, Rare Subtypes, and What's New in Research

CURE OM (the Community United for Research and Education of Ocular Melanoma) is the MRF’s initiative to increase awareness, education and research funding for ocular melanoma, while improving the lives of people affected by this disease. Founded in 2011, the CURE OM initiative excels because of the hard work and dedication of its Patient and Scientific Steering Committees and the generosity of our community.
Cure Melanoma
2025 MRF Denver Gala Courage Award


2025 MRF Denver Gala Courage Award

Lindsay and Paul Zubeck Welcome Everyone to the 14th Annual Denver Gala

Ask The Expert: 2025 ASCO Highlights for the Ocular Melanoma Community

Ocular Melanoma
Last updated: 8/20/2024
Years published: 2018, 2024
Full Report Link @ https://rarediseases.org/rare-diseases/ocular-melanoma/
Acknowledgment
NORD gratefully acknowledges Gioconda Alyea, MD (FMG), MS, National Organization for Rare Disorders, Prithvi Mruthyunjaya, MD, MHS, Associate Professor of Ophthalmology, Ocular Oncology and Vitreoretinal Surgery; Director, Ocular Oncology Service, Byers Eye Institute at Stanford, and the Ocular Melanoma Foundation, for assistance in the preparation of this report.
Disease Overview
Summary
Ocular melanoma is an extremely rare type of cancer that occurs in about 5 out of every million adults. Despite its rarity, it is the most common primary cancer of the eye in adults. A primary cancer means that the cancer begins in the eye itself and has not spread there from another part of the body. The exact cause of ocular melanoma is unknown, but several risk factors have been identified, including genetic factors and possibly environmental influences. Despite this uncertainty, early detection and treatment are crucial for the best outcomes.
Introduction
Eye (ocular) cancer can refer to any cancer that starts in the eye.
The eye is a complex organ with three main parts:
-
Eyeball (globe): The main part of the eye, filled with a jelly-like substance called vitreous humor. It has three layers:
-
Sclera: The tough, white outer layer
-
Uvea: The middle layer, responsible for nourishment and containing the eye’s pigmented cells
-
Retina: The innermost layer, which senses light and is crucial for vision
-
-
Orbit: The tissues surrounding the eyeball
-
Adnexal structures: These include accessory parts like the eyelids and tear glands
Different types of cancer can develop in these areas depending on the type of cells involved. Ocular melanoma typically arises from cells called melanocytes, which produce pigment. When these melanocytes in the choroid become cancerous, the condition is known as choroidal or uveal melanoma. Although these melanocytes are similar to those in the skin, skin melanoma and ocular melanoma are distinct conditions, each with different biological and genetic characteristics. It is rare for skin melanoma to spread to the eye or vice versa.
Uveal melanomas
Ocular melanoma can start at the uveal tract, the colored layer of tissue beneath the white of the eye (sclera). The uvea consists of three parts:
-
Iris: The colored part of the eye which surrounds the pupil
-
Ciliary body: A ring of muscle tissue that releases aqueous humor (a clear fluid) and helps control the lens’s shape for focusing
-
Choroid: The largest part of the uveal tract, located at the back of the eye beneath the retina. This area is rich in blood vessels and pigmented cells.
Most ocular melanomas develop in the choroid or ciliary body. About 9 out of 10 intraocular melanomas occur in these areas. Iris melanomas are less common and usually easier to detect because they often start as a dark spot on the iris that grows over time. Iris melanomas are generally slow-growing and rarely spread, leading to a relatively good prognosis.
Uveal melanomas can spread through the bloodstream, most often reaching the liver, where the cancer can become life-threatening.
Conjunctival melanomas
The conjunctiva is a thin, clear layer covering the sclera. Conjunctival melanomas are extremely rare but tend to be more aggressive. They can grow into nearby structures and spread through both the blood and lymphatic systems, reaching distant organs like the lungs, liver or brain.
Full Report Link @ https://rarediseases.org/rare-diseases/ocular-melanoma/
National Organization for Rare Disorders (NORD)
Leveraging Innovative Trial Designs and Technologies to Accelerate - NORD Scientific Symposium


Leveraging Innovative Trial Designs and Technologies to Accelerate - NORD Scientific Symposium

What’s Next in Rare Disease Data Collection and Clinical Use - NORD Scientific Symposium

Attend the 2025 NORD Rare Diseases and Orphan Products Breakthrough Summit

OIS has set the benchmark for excellence in eye care innovation by uniting pioneering startups, leading strategics, top investors, and renowned clinicians. More than a conference, OIS is a trusted community where ideas take root, partnerships are born, and the future of ophthalmology is shaped. With expertly curated programming, exclusive networking opportunities, and unmatched access to breakthrough technologies, OIS empowers industry leaders to make impactful decisions and build relationships that last.
OIS: Ophthalmology Innovation Source
OIS Pod Ep #422: Rolling Up Sleeves with David Esposito and Connie Chang


OIS Pod Ep #422: Rolling Up Sleeves with David Esposito and Connie Chang

Investor Strategy Understanding your investors and your investment strategies

Novaliq | Christian Roesky, PhD, CEO & Managing Director

Ocular Melanoma Foundation is raising funds, engaging academicians and clinicians, and actively partnering with foundations and other leading agencies supporting cancer research to:
1. Support and accelerate scientific research and discovery and its translation into effective treatment options for patients.
2. Provide resources for education and support to OM patients, their families, and to healthcare professionals treating OM.
3. Act as an advocate within the melanoma and broader cancer community to raise the awareness of OM and the need for a cure.
Ocular Melanoma Foundation
Liver-Directed Therapies: Percutaneous Hepatic Perfusion, Dr. Faries & Dr. Hwong


Liver-Directed Therapies: Percutaneous Hepatic Perfusion, Dr. Faries & Dr. Hwong

Overview of Melanoma Gene Expression Profile (GEP) Test by Castle Biosciences

Patient Q&A with Ocular Melanoma Experts, Dr. Damato, Hovland, Mruthyunjaya, Seider
2017 Eye Am Not Alone
Patient & Caregiver Conference
Hosted by Ocular Melanoma Foundation
2017 OMF EANA Patient & Caregiver Conference
Experience Battling Ocular Melanoma as a Patient and a Mother


Experience Battling Ocular Melanoma as a Patient and a Mother

Clinical Trials for Ocular Melanoma, Discussion with Drs. Mruthyunjaya, Dr. Patel, and Dr. Stecher

Overview of Uveal Melanoma, Dr. Prithvi Mruthyunjaya

The Rare Cancer Alliance
Accelerating Cures Through
Patient-Powered Collaboration
MRA is the world’s largest private nonprofit funder of melanoma research.
We’ve directly invested over $175 million toward scientific discoveries,
and we won’t stop until we achieve our mission of curing melanoma.
Rare Cancer Research Foundation
Pattern.org Walkthrough


Pattern.org Walkthrough

Dr. Jesse Boehm Discusses Importance of Rare Cancer Tissue Donation Through Pattern.org

Accelerating Cancer Research: An Overview of The Rare Cancer Research Foundation

ENTERTAINMENT. Beyond Mishawaka.
